Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | 134,205 | reported | 29 May 2026 | tx 12+330,846−656,089 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | PURCHASE | Chemomab Therapeutics Ltd. | 4,878 | 2.05 USD | |
| 29 May 2026 | PURCHASE | Chemomab Therapeutics Ltd. | 4,926 | 2.08 USD | |
| 29 May 2026 | OTHER | Chemomab Therapeutics Ltd. | 31,712 | — | |
| 29 May 2026 | OTHER | Chemomab Therapeutics Ltd. | 18,750 | — | |
| 03 Jan 2023 | SALE | Chemomab Therapeutics Ltd. | 6,100 | 5.03 USD | |
| 03 Jan 2023 | SALE | Chemomab Therapeutics Ltd. | 7,700 | 5.03 USD | |
| 28 Oct 2016 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 33,725 | 0.00 USD | deriv |
| 15 Mar 2018 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 131,698 | 0.00 USD | deriv |
| 16 Nov 2022 | SALE | Chemomab Therapeutics Ltd. | 324,775 | 2.08 USD | |
| 16 Nov 2022 | SALE | Chemomab Therapeutics Ltd. | 257,248 | 2.08 USD | |
| 28 Oct 2016 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 33,725 | 0.00 USD | deriv |
| 15 Mar 2018 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 131,698 | 0.00 USD | deriv |